NIMG-50 SURVIVAL RATE PREDICTION IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM), USING DYNAMIC CONTRAST ENHANCED MRI AND NESTED MODEL SELECTION TECHNIQUE (NMS)

Similar Items

• NIMG-52 DYNAMIC CONTRAST ENHANCED MR ESTIMATION OF PHARMACOKINETIC PARAMETERS OF GLIOBLASTOMA MULTIFORME TUMORS: A COMPARISON STUDY FOR PERITUMORAL AND GLOBAL ARTERIAL INPUT FUNCTIONS USING MODEL SELECTION TECHNIQUE
  od: Dehkordi, Azimeh N.V., i dr.
  Izdano: (2015)
• NIMG-53 A FUZZY-BASED MODEL TO PREDICT THE SURVIVAL RATE OF PATIENTS WITH GIOBLASTOMA MLTIFORME TUMOR
  od: Dehkordi, Azimeh N.V., i dr.
  Izdano: (2015)
• TMIC-05 DCE-MR PHARMACOKINETIC MODEL EVOLUTION TECHNIQUE FOR PREDICTION OF INTERSTITIAL FLUID PRESSURE IN EMBEDDED TUMORS
  od: Bagher-Ebadian, Hassan, i dr.
  Izdano: (2015)
• Model Selection for DCE-T1 Studies in Glioblastoma
  od: Bagher-Ebadian, Hassan, i dr.
  Izdano: (2011)
• NIMG-04 ADAPTIVE AND STANDARD PHARMACOKINETIC MODEL SELECTION TECHNIQUES IN QUANTITATIVE ANALYSIS OF DYNAMIC CONTRAST ENHANCED MRI STUDIES
  od: Bagher-Ebadian, Hassan, i dr.
  Izdano: (2015)